Normal cerebrospinal fluid glutathione concentrations in Parkinson's disease, Alzheimer's disease and multiple system atrophy

Journal of the Neurological Sciences

Volumn 168, Issue 2, 1999, Pages 112-115

  Konings, C H ^a   Kuiper, M A ^a   Teerlink, T ^a   Mulder, C ^a   Scheltens, Ph ^a   Wolters, E Ch ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease and multiple system atrophy; CSF; Glutathione; Parkinson's disease

Indexed keywords

GLUTATHIONE; LEVODOPA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; SHY DRAGER SYNDROME;

AGED; ALZHEIMER DISEASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLUTATHIONE; HUMANS; MALE; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS;

EID: 0032853190     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00167-7     Document Type: Article

References (20)

1. Siësjo B.K., Agardh C.-D., Bengtsson F. Free radical and brain damage. Cerebrovasc Brain Metab Rev. 1:1989;165-211.
2. Meister A., Anderson M.E. Glutathione. Ann Rev Biochem. 52:1983;711-760.
3. Olanow C.W. An introduction to the free radical hypothesis in Parkinson's disease. Ann Neurol. 32:(Suppl):1992;S2-S9.
4. Jenner P., Olanow C.W. Understanding cell death in Parkinson's disease. Ann Neurol. 44:(Suppl 1):1998;S72-S84.
5. Spencer J.P.E., Jenner P., Halliwell B. Superoxide-dependent depeletion of reduced glutathione by L-DOPA and dopamine. Relevance to Parkinson's disease. NeuroReport. 6:1995;1480-1484.
6. Drukarch B., Jongenelen C.A.M., Schepens E., Langeveld C.H., Stoof J.C. Glutathione is involved in the granular storage of dopamine in rat PC12 pheochromocytoma cells: implications for the pathogenesis of Parkinson's disease. J Neurosci. 16:(19):1996;6038-6042.
7. Sian J., Dexter D.T., Lees A.J., et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol. 36:1994;348-355.
8. Pearce R.K.B., Owen A., Daniel S., Jenner P., Marsden C.D. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J Neural Transm. 104:1997;661-667.
9. Toghi H., Abe T., Saheki M., Hamoto F., Sasaki K., Takahashi S. Reduced and oxidized forms of glutathione and α-tocopherol in the cerebrospinal fluid of parkinsonian patients: comparison between before and after L-DOPA treatment. Neurosci Lett. 184:1995;21-24.
10. Hughes A.J., Ben-Shlomo Y., Daniel S.E., Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 42:1992;1142-1146.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edition, revised. Washington: American Psychiatric Association, 1987.
12. Quinn N. Multiple system atrophy-the nature of the beast. J. Neurol. Neurosurg. Psychiatry. 52:(Suppl):1989;78-89.
13. 123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism. Neurology. 42:1992;556-561.
14. 123I-IBZM Single Photon Emission Computed Tomography. Arch Neurol. 50:1993;513-516.
15. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer' disease. Neurology. 34:1984;939-944.
16. Neuschwander-Tetri B.A., Roll F.J. Glutathione measurement by high-performance liquid chromatography separation and fluorimetric detection of the glutathione-orthophthaldehyde adduct. Annal Biochem. 179:1989;236-241.
17. Jenner P. Presymptomatic detection of Parkinson's disease. J Neural Transm. 40:1993;23-36.
18. Dexter D.T., Sian J., Rose S., et al. Indices of oxidative stress and mitochondrial function in individuals with Incidental Lewy Body Disease. Ann Neurol. 35:1994;38-44.
19. Paroni R., De Vecchi E., Cighetti G., Arcelloni C., Fermo I., Grossi A., Bonini P. HPLC with o-phtaldehyde precolumn derivation to measure total oxidized, and protein-bound glutathione in blood, plasma and tissue. Clin Chem. 41:1995;448-454.
20. Balazs L., Leon M. Evidence of an oxidative challenge in Alzheimer's brain. Neurochem Res. 19:1994;1131-1137.